{"title_page": "Mark Atkinson (scientist)", "text_new": "{{Use mdy dates|date=April 2020}}\n{{Infobox scientist\n| name = Mark Atkinson\n| image = Markatkinson.jpg\n| caption =\n| birth_date = {{birth date and age|1961|03|27}}\n| birth_place = [[Dearborn, Michigan]]\n| death_date =\n| death_place =\n| residence = [[Gainesville, Florida]]\n| nationality = American\n| ethnicity=\n| field = [[Medical research]], [[pathology]], [[type 1 diabetes]], [[clinical trials]]\n| work_institution = [[University of Florida College of Medicine]]\n| alma_mater = [[University of Michigan\u2013Dearborn]] (BS)<br>[[University of Florida]] (PhD)\n| doctoral_advisor =\n| doctoral_students =\n| known_for  = Type 1 diabetes research / humanitarian efforts\n| prizes =\n}}\n'''Mark Atkinson''' (born March 27, 1961) is a medical researcher best known for his contributions to research seeking to predict, prevent, and cure [[type 1 diabetes]].  He is the author of over 500 publications and is one of the world's most cited [[diabetes]] researchers.<ref name=\"ESI Interview\">{{cite web|title=An Interview with Dr. Mark Atkinson|url=http://www.esi-topics.com/diabetes/interviews/DrMarkAtkinson.html|work=Special Topic \"Diabetes\"|publisher=Essential Science Indicators|accessdate=May 5, 2014}}</ref>\n\nAtkinson currently conducts research at the [[University of Florida College of Medicine]], where he is Director for the Diabetes Institute at UF Health. He also is the Executive Director of the Network for Pancreatic Organ donors with Diabetes (nPOD) program.<ref name=\"Atkinson Lab\">{{cite web|title=Atkinson Lab|url=http://diabetes.ufl.edu/research/type-1-diabetes/research-2/atkinson-lab/|publisher=University of Florida Health|accessdate=May 5, 2014}}</ref>\n\nAtkinson has also been widely cited for his humanitarian contributions, particularly his efforts to improve diabetes care, [[Diabetes management|management]], and access to medications and supplies in [[developing nations]].<ref name=\"Hope to Haiti\">{{cite news|last=Dooley|first=Karen|title=Bringing hope to Haiti|url=http://floridaphysician.med.ufl.edu/2010/07/features/test/|accessdate=May 5, 2014|newspaper=Florida Physician|date=Summer 2010}}</ref>\n\n==Background and education==\nMark Atkinson was born and raised in [[southeastern Michigan]]. He attended the [[University of Michigan\u2013Dearborn|University of Michigan \u2013 Dearborn]] where he received a bachelor of Science in [[microbiology]] in 1983. Atkinson next received a Ph.D. from the Department of [[Pathology]] at the [[University of Florida]] in 1987.<ref name=\"Faculty Page\">{{cite web |url=https://umdearborn.edu/news/articles/lasting-impact-um-dearborn-recognizes-seven-alumni-difference-makers-during-annual-awards |title=Lasting impact: UM-Dearborn recognizes seven Alumni Difference Makers during annual awards ceremony}}</ref>\n\nWhile at the University of Florida, Atkinson studied under diabetes researcher Dr. Noel Maclaren, who became his mentor and fostered Atkinson's interest in type 1 diabetes research. His work with Maclaren led Atkinson to develop his three goals of determining what causes type 1 diabetes, identifying a means to predict T1D, and developing a way to prevent and cure the disease.<ref name=\"Endocrinology and Metabolism Interview\">{{cite interview |last=Atkinson |first=Mark |interviewer=Rona Williamson |title=Trying to Make a Difference for Those With Type 1 Diabetes |journal=Expert Review of Endocrinology & Metabolism |date=July 2013 |volume=8 |issue=4 |pages=323\u2013327 |doi=10.1586/17446651.2013.811869 |url=http://www.medscape.com/viewarticle/809124}}</ref>\n\n==Academic career==\nAtkinson has been teaching and conducting research in the Departments of Pathology and Pediatrics at the University of Florida College of Medicine since 1988.<ref name=\"Faculty Page\" /> He is currently the [[American Diabetes Association]] Eminent Scholar for Diabetes Research and the Jeffrey Keene Family Professor at the University of Florida, as well as the Director for the Diabetes Institute at that institution.<ref>{{cite news|last=Schweers|first=Jeff|title=UF Foundation names two UF professors as preeminence award winners |url=http://www.gainesville.com/article/20131007/ARTICLES/131009668|accessdate=May 5, 2014|newspaper=The Gainesville Sun|date=October 7, 2013}}</ref>\n\n==Type 1 diabetes research==\nAtkinson's research activities have a broad scope, but most fall under the umbrella of preventing and curing type 1 diabetes. Specific areas of focus include disease prediction, the role of environment in the initiation of type 1 diabetes, [[stem cells]] and beta cell regeneration, [[pancreatic]] pathology, [[clinical trials]] seeking to prevent or reverse type 1 diabetes, the identification of [[Biomarker (medicine)|markers]] of immunological tolerance, and devising ways to instill proper immunoregulation. Atkinson has been the recipient of funding awards from entities such as the [[National Institutes of Health]], [[JDRF]], the [[American Diabetes Association]], and [[the Leona M. and Harry B. Helmsley Charitable Trust]].<ref name=\"Atkinson Lab\" />\n\n===Research approaches===\nAtkinson has conducted numerous studies that take different approaches to predicting, preventing, and curing type 1 diabetes. His earliest efforts focused on the use of [[autoantibodies]], both anti-insulin and anti-[[glutamic acid decarboxylase]] (GAD), for that purpose.  He was also amongst the first to describe cellular immune responses against GAD in both humans and the [[NOD mouse]] model of type 1 diabetes. He has extensively utilized NOD mice as a means to identify agents that could be translated to studies seeking to prevent or reverse type 1 diabetes but at the same time, has stated that such efforts need be approached with caution.<ref>{{cite journal|last=Atkinson|first=Mark A.|title=Evaluating preclinical efficacy|journal=Science Translational Medicine|date=August 17, 2011 |volume=3|issue=96|series=96|page=96cm22|doi=10.1126/scitranslmed.3002757|url=http://stm.sciencemag.org/content/3/96/96cm22.abstract |accessdate=May 5, 2014|pmid=21849661}}</ref> His publication in the journal Nature Medicine noting the nearly 200 ways to prevent diabetes in that animal model elicited mixed responses from the research community.<ref>{{cite journal|last=Atkinson|first=Mark A. |author2=Leiter, Edward H.|title=The NOD mouse model of type 1 diabetes: As good as it gets?|journal=Nature Medicine|date=1999 |volume=5|issue=6|pages=601\u2013604|doi=10.1038/9442|pmid=10371488}}</ref>\n\nAtkinson was one of the first to propose \u201c[[combination therapy|combination therapies]]\u201d to prevent or reverse the disease, as well as the repurposing of existing treatments and agents already approved for other diseases and conditions.<ref name=\"Endocrinology and Metabolism Interview\" /> Atkinson has led or contributed to clinical trials utilizing several types of interventions to stop the progression of or reverse type 1 diabetes, including prophylactic [[insulin]], GAD, [[cord blood]], cord blood plus [[Omega-3 fatty acid|Omega-3 FA]], [[granulocyte colony-stimulating factor]] (GCSF), and [[anti-thymocyte globulin]] (ATG) plus GCSF.<ref name=\"Baylor Microbiome\">{{cite web|title=Project: Microbiome and Type 1 Diabetes|url=https://www.bcm.edu/departments/molecular-virology-and-microbiology/cmmr/index.cfm?pmid=23895|publisher=Baylor College of Medicine|accessdate=May 5, 2014|url-status=dead |archiveurl=https://web.archive.org/web/20140505235434/https://www.bcm.edu/departments/molecular-virology-and-microbiology/cmmr/index.cfm?pmid=23895|archivedate=May 5, 2014}}</ref>\n\nAtkinson is currently leading an NIH funded clinical research trial aiming to assess immune function during different stages of type 1 diabetes. The goal is to learn more about the genetics and immune function of [[blood cells]], diet, and [[viruses]] and how they relate to the progression of T1D.<ref>{{cite web|title=Immunological Studies in Type 1 Diabetes |url=http://diabetes.ufl.edu/research/find-a-diabetes-research-study/immunological-studies-in-type-1-diabetes/|publisher=The Diabetes Institute at University of Florida Health|accessdate=May 5, 2014|url-status=dead |archiveurl=https://web.archive.org/web/20140505233347/http://diabetes.ufl.edu/research/find-a-diabetes-research-study/immunological-studies-in-type-1-diabetes/|archivedate=May 5, 2014}}</ref>\n\nAtkinson is also active in studies assessing the human intestinal [[microbiome]], pancreatic pathology, human pancreatic weight and beta cell development, as well as improving methods of data management.<ref name=\"Baylor Microbiome\" />\n\n===nPOD===\nAtkinson is the Executive Director for the Network for Pancreatic Organ donors with Diabetes (nPOD) program, the world's largest \"open access\" [[biobank]] of human tissues from persons with or at varying levels of risk for type 1 diabetes. nPOD is funded by [[JDRF]] and The [[the Leona M. and Harry B. Helmsley Charitable Trust|Leona M. and Harry B. Helmsley Charitable Trust]].<ref>{{cite news |last=Chun|first=Diane|title=UF to lead in diabetes research |url=http://www.gainesville.com/article/20070904/NEWS/709040312 |accessdate=May 5, 2014|newspaper=The Gainesville Sun|date=September 4, 2007}}</ref>\n\nThrough nPOD, Atkinson and other collaborators support research utilizing transplant-grade human tissues obtained from [[organ donors]], including [[pancreas]], [[spleen]], [[whole blood]], [[Serum (blood)|serum]], [[lymph nodes]], pancreatic lymph nodes, thymus, skin and [[bone marrow]]. The goal is to better understand the causes of type 1 diabetes and identify potential approaches to curing the disease. Atkinson has directed nPOD since its founding in 2007, it has and continued to support over 250 different investigators in some 200 research projects in 20 countries worldwide.<ref name=\"Endocrinology and Metabolism Interview\" />\n\n===Research collaborations===\nIn addition to nPOD, Atkinson participates in a number of other collaborative research efforts. He is one of ten members of the Brehm Coalition for Type 1 Diabetes Research, and one of four initial members of the Leona M. and Harry B. Helmsley Charitable Trust's Type 1 Diabetes Research Initiative.<ref>{{cite web|title=Mark Atkinson|url=https://www.brehmcoalition.org/about/leadership04.php |publisher=Brehm Coalition|accessdate=May 5, 2014}}</ref> Atkinson also collaborates on a number of research initiatives with investigators around the globe as well as with his colleagues at the University of Florida's Diabetes Institute.<ref>{{cite news |last=Stewart|first=Sarah L.|title=Doing Battle with Diabetes|url=http://magazine.ufl.edu/2011/10/battle-with-diabetes/|accessdate=May 5, 2014|newspaper=Florida Magazine|date=October 6, 2011|url-status=dead |archiveurl=https://web.archive.org/web/20140505233011/http://magazine.ufl.edu/2011/10/battle-with-diabetes/|archivedate=May 5, 2014}}</ref>\n\nAtkinson also serves as Director of the Human Biomolecular Atlas Program (HuBMAP) at the University of Florida. HuBMAP's mission is to develop a 3-D map of the human body at a single-cell level.\n\n==Leadership and influence in the field==\nAtkinson is the author of over 425 peer-reviewed publications as well as several book chapters. Expertscape ranks Atkinson as one of the ten most published diabetes researchers in the world, and with an all time [[h-index]] of 91, he is one of the most highly cited diabetes researchers in the world.<ref name=\"ESI Interview\" />\n\nAtkinson provides leadership to numerous entities that focus on research and service to the type 1 diabetes community, and currently provides administrative or advisory service to JDRF, the American Diabetes Association, Diapedia, the National Institutes of Health (NIH), and the Immunology of Diabetes Society. He is a charter member of the NIH's Immune Tolerance Network Scientific Advisory Board, former Chair of the NIH's Human Islet Research Network (HIRN), and a steering committee member of NIH TrialNet.<ref name=\"Endocrinology and Metabolism Interview\" />\n\nAtkinson also formerly served as an Associate Editor for the journal ''[[Diabetes (journal)|Diabetes]]''. He now serves as ad hoc Editor-in-Chief for that journal as well as ''[[Diabetes Care]]''.<ref>{{cite web|title=The American Diabetes Association Announces New Editors for Diabetes Journal|url=http://www.diabetes.org/newsroom/press-releases/2011/new-editors-for-diabetes-journal.html|publisher=American Diabetes Association|accessdate=May 5, 2014}}</ref>\n\n==Commercial and industry work==\nAlong with his colleagues at the University of Florida Diabetes Institute, Atkinson is pursuing a [[vaccine]] strategy for preventing type 1 diabetes. The approach seeks to eliminate the autoimmune response directed at insulin that is present in patients with the disease by generating [[antigen]]-specific Tregs ([[regulatory T cells]]) in response to the antigens of interest rather than try to eliminate the autoreactive destructive cells. To further this line of research, Atkinson and other investigators started a spin-off company called OneVax, LLC.<ref>{{cite news|title=Dealing with diabetes |url=http://bruskolab.sites.medinfo.ufl.edu/files/2012/08/Todd_Brusko_Final.pdf|accessdate=May 5, 2014|newspaper=International Innovation|date=September 20, 2012|url-status=dead |archiveurl=https://web.archive.org/web/20131113184958/http://bruskolab.sites.medinfo.ufl.edu/files/2012/08/Todd_Brusko_Final.pdf|archivedate=November 13, 2013}}</ref> OneVax seeks to develop and commercialize a novel vaccine formula to prevent and/or reverse type 1 diabetes, incorporating [[biomaterials]] and [[polymers]] for applications including multicomponent and time-release drug delivery. Atkinson serves as CEO of OneVax.<ref>{{cite web|title=About us|url=http://www.onevax.com/about-us.html|publisher=OneVax|accessdate=May 5, 2014|archive-url=https://web.archive.org/web/20140505231649/http://www.onevax.com/about-us.html|archive-date=May 5, 2014|url-status=dead}}</ref>\n\n==Honors and awards==\n* 2004: [[Mary Tyler Moore]] and S. Robert Levine, M.D. Excellence in Clinical Research Award from JDRF<ref>{{cite news |last=Chun|first=Diane|title=Three UF researchers win diabetes award |url=http://www.gainesville.com/article/20080802/news/857216585 |accessdate=May 6, 2014|newspaper=The Gainesville Sun|date=August 2, 2008}}</ref>\n* 2016: Outstanding Alumni of the Year Award from The University of Michigan-Dearborn<ref name=\"Faculty Page\" />\n*2018: University of Florida College of Medicine Lifetime Achievement Award<ref>{{Cite news|url=https://facultycouncil.med.ufl.edu/faculty-information/lifetime-achievement-award/|title=Lifetime Achievement Award|access-date=September 14, 2018|language=en}}</ref>\n*2018: American Diabetes Association Humanitarian Award<ref>{{Cite web|url=http://www.diabetes.org/newsroom/press-releases/2018/carol-and-mark-atkinson-receive-ada-humanitarian-award.html|title=Carol and Mark A. Atkinson, PhD, Receive American Diabetes Association's Humanitarian Award|website=American Diabetes Association|language=en|access-date=September 14, 2018}}</ref>\n*2018: American Diabetes Association Albert Renold Award<ref>{{Cite web|url=http://www.diabetes.org/newsroom/press-releases/2018/2018-renold-award-mark-atkinson.html|title=Mark A. Atkinson, PhD, Named American Diabetes Association's \u00ae 2018 Albert Renold Award Recipient|website=American Diabetes Association|language=en|access-date=September 14, 2018}}</ref>\n*2018: In December 2018 [[Expertscape]] recognized Dr. Atkinson as one of the top ten experts in the world for expertise in [[Diabetes Mellitus Type 1]].<ref name=\"rank_diabetes_mellitus,_type_1\">{{cite web|url=http://www.expertscape.com/the-leaders/diabetes+mellitus%2C+type+1 |title=Expertscape: Diabetes Mellitus, Type 1, December 2018 |publisher=expertscape.com |date=December 2018 |accessdate=December 12, 2018 }}</ref>\n*2019: Novo Nordisk Jacob\u00e6us Award<ref>{{cite web |url=https://novonordiskfonden.dk/en/news/recipient-of-the-2019-jacobaeus-prize-is-challenging-longstanding-dogmas-in-type-1-diabetes/ |title=Recipient of the 2019 Jacob\u00e6us Prize is challenging longstanding dogmas in type 1 diabetes |language=da |publisher=Novo Nordisk Foundation |access-date=November 9, 2019}}</ref>\n*2019: Added to the University of Florida\u2019s College of Medicine Wall of Fame\n\n==Humanitarian interests==\nAtkinson has joined with other leaders calling for a means to provide insulin to 100 percent of the world's population who need it by 2022, the centennial anniversary of insulin availability.  Atkinson also serves as an Advisory Board Member to the Life for a Child program.<ref name=\"Endocrinology and Metabolism Interview\" />\n\nAtkinson has served with the Haitian Foundation for Diabetes and Cardiovascular Diseases (Fondation Haitienne de Diabete et de Maladies Cardio-Vasculaires), overseen by Nancy Larco. Atkinson has traveled to Haiti to provide medical, dental, and educational assistance, including after the [[2010 Haiti earthquake]].<ref name=\"Hope to Haiti\" />\n\nAtkinson and his wife co-founded a non-profit organization, Hope on the Move, for humanitarian causes, primarily related to providing medical and dental care to developing nations.<ref>{{cite news|title=\"Hope on the Move\" for Haiti|url=http://www.wcjb.com/local-news/2011/01/hope-move-haiti|accessdate=May 6, 2014|newspaper=WCJB-TV 20|date=January 12, 2011}}</ref> Atkinson serves as secretary, treasurer and director of Hope on the Move.<ref>{{cite web|title=About Us|url=http://www.hopeonthemove.org/about-us.html|publisher=Hope on the Move|accessdate=May 6, 2014}}</ref>\n\nAtkinson is the president of Insulin for Life-USA, a non-profit organization that collects insulin, test strips, and other diabetes management supplies and distributes them to needy individuals in developing nations as well as in the United States following natural disasters.<ref>{{cite web|title=Who We Are|url=http://www.ifl-usa.org/2/post/2013/01/who-we-are.html|publisher=Insulin for Life USA|accessdate=May 6, 2014|url-status=dead|archiveurl=https://web.archive.org/web/20140506182424/http://www.ifl-usa.org/2/post/2013/01/who-we-are.html|archivedate=May 6, 2014}}</ref>\n\n==Selected publications==\n* {{cite journal | last1 = Atkinson | first1 = MA | last2 = Eisenbarth | first2 = GS | last3 = Michels | first3 = AW | year = 2014 | title = Type 1 diabetes | journal = [[The Lancet]] | volume = 383 | issue = 9911| pages = 69\u201382 | doi = 10.1016/S0140-6736(13)60591-7 | pmid = 23890997 | pmc=4380133}}\n* {{cite journal | last1 = Pugliese | first1 = A | last2 = Yang | first2 = M | last3 = Kusmarteva | first3 = I | last4 = Heiple | first4 = T | last5 = Vendrame | first5 = F | last6 = Wasserfall | first6 = C | last7 = Rowe | first7 = P | last8 = Moraski | first8 = JM | last9 = Ball | first9 = S | last10 = Jebson | first10 = L | last11 = Schatz | first11 = DA | last12 = Gianani | first12 = R | last13 = Burke | first13 = GW | last14 = Nierras | first14 = C | last15 = Staeva | first15 = T | last16 = Kaddis | first16 = JS | last17 = Campbell-Thompson | first17 = M | last18 = Atkinson | first18 = MA | year = 2014 | title = The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings | journal = Diabetes | volume = 15 | issue = 1| pages = 1\u20139 | doi = 10.1111/pedi.12097 | pmid = 24325575 | pmc=4282794}}\n* {{cite journal | last1 = Atkinson | first1 = MA | last2 = Ogle | first2 = GD | date = Dec 2013 | title = Improving diabetes care in resource-poor countries: challenges and opportunities | url = | journal = The Lancet Diabetes & Endocrinology | volume = 1 | issue = 4| pages = 268\u201370 | doi = 10.1016/S2213-8587(13)70172-4 | pmid = 24622408 }}\n* {{cite journal | last1 = Staeva | first1 = TP | last2 = Chatenoud | first2 = L | last3 = Insel | first3 = R | last4 = Atkinson | first4 = MA | date = Jan 2013 | title = Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials | journal = Diabetes | volume = 62 | issue = 1| pages = 9\u201317 | doi = 10.2337/db12-0562 | pmid = 23258904 | pmc=3526042}}\n* {{cite journal | last1 = Atkinson | first1 = MA | date = Aug 2011 | title = Evaluating preclinical efficacy | url = | journal = Science Translational Medicine | volume = 3 | issue = 96| page = 22 | doi = 10.1126/scitranslmed.3002757 | pmid = 21849661 }}\n\n==References==\n{{Reflist}}\n\n==External links==\n* [http://pathology.ufl.edu/faculty/experimental-pathology/mark-a-atkinson/ Mark Atkinson] at University of Florida College of Medicine Department of Pathology, Immunology, and Laboratory Medicine\n* [http://diabetes.ufl.edu/research/type-1-diabetes/research-2/atkinson-lab/ Atkinson Lab] at University of Florida Health Diabetes Institute\n* [http://www.jdrfnpod.org/ Network for Pancreatic Organ Donors with Diabetes] (nPOD)\n* [http://www.hopeonthemove.org/ Hope on the Move]\n* [http://www.ifl-usa.org/ Insulin for Life USA]\n* List of [http://www.pubfacts.com/author/Mark+Atkinson authored publications]\n\n{{Authority control}}\n\n{{DEFAULTSORT:Atkinson, Mark}}\n[[Category:1961 births]]\n[[Category:American medical researchers]]\n[[Category:Living people]]\n[[Category:University of Michigan\u2013Dearborn alumni]]\n", "text_old": "{{Infobox scientist\n| name = Mark Atkinson\n| image = Markatkinson.jpg\n| image_size =\n| caption =\n| birth_date = March 27, 1961\n| birth_place = [[Dearborn, Michigan]]\n| death_date =\n| death_place =\n| residence = [[Gainesville, Florida]]\n| nationality = American\n| ethnicity=\n| field = [[Medical research]], [[pathology]], [[type 1 diabetes]], [[clinical trials]]\n| work_institution = [[University of Florida College of Medicine]]\n| alma_mater = [[University of Michigan\u2013Dearborn|The University of Michigan - Dearborn]] (B.S.), [[University of Florida]] (Ph.D.)\n| doctoral_advisor =\n| doctoral_students =\n| known_for  = Type 1 diabetes research / humanitarian efforts\n| prizes =\n}}\n'''Mark Atkinson''' (born March 27, 1961) is a medical researcher best known for his contributions to research seeking to predict, prevent, and cure [[type 1 diabetes]].  He is the author of over 500 publications and is one of the world's most cited [[diabetes]] researchers.<ref name=\"ESI Interview\">{{cite web|title=An Interview with Dr. Mark Atkinson|url=http://www.esi-topics.com/diabetes/interviews/DrMarkAtkinson.html|work=Special Topic \"Diabetes\"|publisher=Essential Science Indicators|accessdate=5 May 2014}}</ref>\n\nAtkinson currently conducts research at the [[University of Florida College of Medicine]], where he is Director for the Diabetes Institute at UF Health. He also is the Executive Director of the Network for Pancreatic Organ donors with Diabetes (nPOD) program.<ref name=\"Atkinson Lab\">{{cite web|title=Atkinson Lab|url=http://diabetes.ufl.edu/research/type-1-diabetes/research-2/atkinson-lab/|publisher=University of Florida Health|accessdate=5 May 2014}}</ref>\n\nAtkinson has also been widely cited for his humanitarian contributions, particularly his efforts to improve diabetes care, [[Diabetes management|management]], and access to medications and supplies in [[developing nations]].<ref name=\"Hope to Haiti\">{{cite news|last=Dooley|first=Karen|title=Bringing hope to Haiti|url=http://floridaphysician.med.ufl.edu/2010/07/features/test/|accessdate=5 May 2014|newspaper=Florida Physician|date=Summer 2010}}</ref>\n\n==Background and education==\nMark Atkinson was born and raised in [[southeastern Michigan]]. He attended the [[University of Michigan\u2013Dearborn|University of Michigan \u2013 Dearborn]] where he received a B.S. in [[microbiology]] in 1983. Atkinson next received a Ph.D. from the Department of [[Pathology]] at the [[University of Florida]] in 1987.<ref name=\"Faculty Page\">{{cite web|url=https://umdearborn.edu/news/articles/lasting-impact-um-dearborn-recognizes-seven-alumni-difference-makers-during-annual-awards|title=Lasting impact: UM-Dearborn recognizes seven Alumni Difference Makers during annual awards ceremony}}</ref>\n\nWhile at the University of Florida, Atkinson studied under diabetes researcher Dr. Noel Maclaren, who became his mentor and fostered Atkinson's interest in type 1 diabetes research. His work with Maclaren led Atkinson to develop his three goals of determining what causes type 1 diabetes, identifying a means to predict T1D, and developing a way to prevent and cure the disease.<ref name=\"Endocrinology and Metabolism Interview\">{{cite interview |last=Atkinson |first=Mark |interviewer=Rona Williamson |title=Trying to Make a Difference for Those With Type 1 Diabetes |journal=Expert Review of Endocrinology & Metabolism |date=July 2013 |volume=8 |issue=4 |pages=323\u2013327 |doi=10.1586/17446651.2013.811869 |url=http://www.medscape.com/viewarticle/809124}}</ref>\n\n==Academic career==\nAtkinson has been teaching and conducting research in the Departments of Pathology and Pediatrics at the University of Florida College of Medicine since 1988.<ref name=\"Faculty Page\" /> He is currently the [[American Diabetes Association]] Eminent Scholar for Diabetes Research and the Jeffrey Keene Family Professor at the University of Florida, as well as the Director for the Diabetes Institute at that institution.<ref>{{cite news|last=Schweers|first=Jeff|title=UF Foundation names two UF professors as preeminence award winners|url=http://www.gainesville.com/article/20131007/ARTICLES/131009668|accessdate=5 May 2014|newspaper=The Gainesville Sun|date=7 October 2013}}</ref>\n\n==Type 1 diabetes research==\nAtkinson's research activities have a broad scope, but most fall under the umbrella of preventing and curing type 1 diabetes. Specific areas of focus include disease prediction, the role of environment in the initiation of type 1 diabetes, [[stem cells]] and beta cell regeneration, [[pancreatic]] pathology, [[clinical trials]] seeking to prevent or reverse type 1 diabetes, the identification of [[Biomarker (medicine)|markers]] of immunological tolerance, and devising ways to instill proper immunoregulation. Atkinson has been the recipient of funding awards from entities such as the [[National Institutes of Health]], [[JDRF]], the [[American Diabetes Association]], and [[the Leona M. and Harry B. Helmsley Charitable Trust]].<ref name=\"Atkinson Lab\" />\n\n===Research approaches===\nAtkinson has conducted numerous studies that take different approaches to predicting, preventing, and curing type 1 diabetes. His earliest efforts focused on the use of [[autoantibodies]], both anti-insulin and anti-[[glutamic acid decarboxylase]] (GAD), for that purpose.  He was also amongst the first to describe cellular immune responses against GAD in both humans and the [[NOD mouse]] model of type 1 diabetes. He has extensively utilized NOD mice as a means to identify agents that could be translated to studies seeking to prevent or reverse type 1 diabetes but at the same time, has stated that such efforts need be approached with caution.<ref>{{cite journal|last=Atkinson|first=Mark A.|title=Evaluating preclinical efficacy|journal=Science Translational Medicine|date=17 August 2011|volume=3|issue=96|series=96|page=96cm22|doi=10.1126/scitranslmed.3002757|url=http://stm.sciencemag.org/content/3/96/96cm22.abstract|accessdate=5 May 2014|pmid=21849661}}</ref> His publication in the journal Nature Medicine noting the nearly 200 ways to prevent diabetes in that animal model elicited mixed responses from the research community.<ref>{{cite journal|last=Atkinson|first=Mark A.|author2=Leiter, Edward H.|title=The NOD mouse model of type 1 diabetes: As good as it gets?|journal=Nature Medicine|date=1999|volume=5|issue=6|pages=601\u2013604|doi=10.1038/9442|pmid=10371488}}</ref>\n\nAtkinson was one of the first to propose \u201c[[combination therapy|combination therapies]]\u201d to prevent or reverse the disease, as well as the repurposing of existing treatments and agents already approved for other diseases and conditions.<ref name=\"Endocrinology and Metabolism Interview\" /> Atkinson has led or contributed to clinical trials utilizing several types of interventions to stop the progression of or reverse type 1 diabetes, including prophylactic [[insulin]], GAD, [[cord blood]], cord blood plus [[Omega-3 fatty acid|Omega-3 FA]], [[granulocyte colony-stimulating factor]] (GCSF), and [[anti-thymocyte globulin]] (ATG) plus GCSF.<ref name=\"Baylor Microbiome\">{{cite web|title=Project: Microbiome and Type 1 Diabetes|url=https://www.bcm.edu/departments/molecular-virology-and-microbiology/cmmr/index.cfm?pmid=23895|publisher=Baylor College of Medicine|accessdate=5 May 2014|url-status=dead|archiveurl=https://web.archive.org/web/20140505235434/https://www.bcm.edu/departments/molecular-virology-and-microbiology/cmmr/index.cfm?pmid=23895|archivedate=5 May 2014}}</ref>\n\nAtkinson is currently leading an NIH funded clinical research trial aiming to assess immune function during different stages of type 1 diabetes. The goal is to learn more about the genetics and immune function of [[blood cells]], diet, and [[viruses]] and how they relate to the progression of T1D.<ref>{{cite web|title=Immunological Studies in Type 1 Diabetes|url=http://diabetes.ufl.edu/research/find-a-diabetes-research-study/immunological-studies-in-type-1-diabetes/|publisher=The Diabetes Institute at University of Florida Health|accessdate=5 May 2014|url-status=dead|archiveurl=https://web.archive.org/web/20140505233347/http://diabetes.ufl.edu/research/find-a-diabetes-research-study/immunological-studies-in-type-1-diabetes/|archivedate=5 May 2014}}</ref>\n\nAtkinson is also active in studies assessing the human intestinal [[microbiome]], pancreatic pathology, human pancreatic weight and beta cell development, as well as improving methods of data management.<ref name=\"Baylor Microbiome\" />\n\n===nPOD===\nAtkinson is the Executive Director for the Network for Pancreatic Organ donors with Diabetes (nPOD) program, the world's largest \"open access\" [[biobank]] of human tissues from persons with or at varying levels of risk for type 1 diabetes. nPOD is funded by [[JDRF]] and The [[the Leona M. and Harry B. Helmsley Charitable Trust|Leona M. and Harry B. Helmsley Charitable Trust]].<ref>{{cite news|last=Chun|first=Diane|title=UF to lead in diabetes research|url=http://www.gainesville.com/article/20070904/NEWS/709040312|accessdate=5 May 2014|newspaper=The Gainesville Sun|date=4 September 2007}}</ref>\n\nThrough nPOD, Atkinson and other collaborators support research utilizing transplant-grade human tissues obtained from [[organ donors]], including [[pancreas]], [[spleen]], [[whole blood]], [[Serum (blood)|serum]], [[lymph nodes]], pancreatic lymph nodes, thymus, skin and [[bone marrow]]. The goal is to better understand the causes of type 1 diabetes and identify potential approaches to curing the disease. Atkinson has directed nPOD since its founding in 2007, it has and continued to support over 250 different investigators in some 200 research projects in 20 countries worldwide.<ref name=\"Endocrinology and Metabolism Interview\" />\n\n===Research collaborations===\nIn addition to nPOD, Atkinson participates in a number of other collaborative research efforts. He is one of ten members of the Brehm Coalition for Type 1 Diabetes Research, and one of four initial members of the Leona M. and Harry B. Helmsley Charitable Trust's Type 1 Diabetes Research Initiative.<ref>{{cite web|title=Mark Atkinson|url=https://www.brehmcoalition.org/about/leadership04.php|publisher=Brehm Coalition|accessdate=5 May 2014}}</ref> Atkinson also collaborates on a number of research initiatives with investigators around the globe as well as with his colleagues at the University of Florida's Diabetes Institute.<ref>{{cite news|last=Stewart|first=Sarah L.|title=Doing Battle with Diabetes|url=http://magazine.ufl.edu/2011/10/battle-with-diabetes/|accessdate=5 May 2014|newspaper=Florida Magazine|date=6 October 2011|url-status=dead|archiveurl=https://web.archive.org/web/20140505233011/http://magazine.ufl.edu/2011/10/battle-with-diabetes/|archivedate=5 May 2014}}</ref>\n\nAtkinson also serves as Director of the Human Biomolecular Atlas Program (HuBMAP) at the University of Florida. \u00a0HuBMAP\u2019s mission is to develop a 3-D map of the human body at a single-cell level.\n\n==Leadership and influence in the field==\nAtkinson is the author of over 425 peer-reviewed publications as well as several book chapters. Expertscape ranks Atkinson as one of the ten most published diabetes researchers in the world, and with an all time [[h-index]] of 91, he is one of the most highly cited diabetes researchers in the world.<ref name=\"ESI Interview\" />\n\nAtkinson provides leadership to numerous entities that focus on research and service to the type 1 diabetes community, and currently provides administrative or advisory service to JDRF, the American Diabetes Association, Diapedia, the National Institutes of Health (NIH), and the Immunology of Diabetes Society. He is a charter member of the NIH's Immune Tolerance Network Scientific Advisory Board, former Chair of the NIH's Human Islet Research Network (HIRN), and a steering committee member of NIH TrialNet.<ref name=\"Endocrinology and Metabolism Interview\" />\n\nAtkinson also formerly served as an Associate Editor for the journal ''[[Diabetes (journal)|Diabetes]]''. He now serves as ad hoc Editor-in-Chief for that journal as well as ''[[Diabetes Care]]''.<ref>{{cite web|title=The American Diabetes Association Announces New Editors for Diabetes Journal|url=http://www.diabetes.org/newsroom/press-releases/2011/new-editors-for-diabetes-journal.html|publisher=American Diabetes Association|accessdate=5 May 2014}}</ref>\n\n==Commercial and industry work==\nAlong with his colleagues at the University of Florida Diabetes Institute, Atkinson is pursuing a [[vaccine]] strategy for preventing type 1 diabetes. The approach seeks to eliminate the autoimmune response directed at insulin that is present in patients with the disease by generating [[antigen]]-specific Tregs ([[regulatory T cells]]) in response to the antigens of interest rather than try to eliminate the autoreactive destructive cells. To further this line of research, Atkinson and other investigators started a spin-off company called OneVax, LLC.<ref>{{cite news|title=Dealing with diabetes|url=http://bruskolab.sites.medinfo.ufl.edu/files/2012/08/Todd_Brusko_Final.pdf|accessdate=5 May 2014|newspaper=International Innovation|date=20 September 2012|url-status=dead|archiveurl=https://web.archive.org/web/20131113184958/http://bruskolab.sites.medinfo.ufl.edu/files/2012/08/Todd_Brusko_Final.pdf|archivedate=13 November 2013}}</ref> OneVax seeks to develop and commercialize a novel vaccine formula to prevent and/or reverse type 1 diabetes, incorporating [[biomaterials]] and [[polymers]] for applications including multicomponent and time-release drug delivery. Atkinson serves as CEO of OneVax.<ref>{{cite web|title=About us|url=http://www.onevax.com/about-us.html|publisher=OneVax|accessdate=5 May 2014|archive-url=https://web.archive.org/web/20140505231649/http://www.onevax.com/about-us.html|archive-date=5 May 2014|url-status=dead}}</ref>\n\n==Honors and awards==\n* 2004: [[Mary Tyler Moore]] and S. Robert Levine, M.D. Excellence in Clinical Research Award from JDRF<ref>{{cite news|last=Chun|first=Diane|title=Three UF researchers win diabetes award|url=http://www.gainesville.com/article/20080802/news/857216585|accessdate=6 May 2014|newspaper=The Gainesville Sun|date=2 August 2008}}</ref>\n* 2016: Outstanding Alumni of the Year Award from The University of Michigan-Dearborn<ref name=\"Faculty Page\" />\n*2018: University of Florida College of Medicine Lifetime Achievement Award<ref>{{Cite news|url=https://facultycouncil.med.ufl.edu/faculty-information/lifetime-achievement-award/|title=Lifetime Achievement Award|access-date=2018-09-14|language=en}}</ref>\n*2018: American Diabetes Association Humanitarian Award<ref>{{Cite web|url=http://www.diabetes.org/newsroom/press-releases/2018/carol-and-mark-atkinson-receive-ada-humanitarian-award.html|title=Carol and Mark A. Atkinson, PhD, Receive American Diabetes Association's Humanitarian Award|website=American Diabetes Association|language=en|access-date=2018-09-14}}</ref>\n*2018: American Diabetes Association Albert Renold Award<ref>{{Cite web|url=http://www.diabetes.org/newsroom/press-releases/2018/2018-renold-award-mark-atkinson.html|title=Mark A. Atkinson, PhD, Named American Diabetes Association's \u00ae 2018 Albert Renold Award Recipient|website=American Diabetes Association|language=en|access-date=2018-09-14}}</ref>\n*2018: In December 2018 [[Expertscape]] recognized Dr. Atkinson as one of the top ten experts in the world for expertise in [[Diabetes Mellitus Type 1]].<ref name=\"rank_diabetes_mellitus,_type_1\">{{cite web|url=http://www.expertscape.com/the-leaders/diabetes+mellitus%2C+type+1 |title=Expertscape: Diabetes Mellitus, Type 1, December 2018 |publisher=expertscape.com |date=December 2018 |accessdate=2018-12-12 }}</ref>\n*2019: Novo Nordisk Jacob\u00e6us Award<ref>{{cite web |url=https://novonordiskfonden.dk/en/news/recipient-of-the-2019-jacobaeus-prize-is-challenging-longstanding-dogmas-in-type-1-diabetes/ |title=Recipient of the 2019 Jacob\u00e6us Prize is challenging longstanding dogmas in type 1 diabetes |language=da |publisher=Novo Nordisk Foundation |access-date=2019-11-09}}</ref>\n*2019: Added to the University of Florida\u2019s College of Medicine Wall of Fame\n\n==Humanitarian interests==\nAtkinson has joined with other leaders calling for a means to provide insulin to 100 percent of the world's population who need it by 2022, the centennial anniversary of insulin availability.  Atkinson also serves as an Advisory Board Member to the Life for a Child program.<ref name=\"Endocrinology and Metabolism Interview\" />\n\nAtkinson has served with the Haitian Foundation for Diabetes and Cardiovascular Diseases (Fondation Haitienne de Diabete et de Maladies Cardio-Vasculaires), overseen by Nancy Larco. Atkinson has traveled to Haiti to provide medical, dental, and educational assistance, including after the [[2010 Haiti earthquake]].<ref name=\"Hope to Haiti\" />\n\nAtkinson and his wife co-founded a non-profit organization, Hope on the Move, for humanitarian causes, primarily related to providing medical and dental care to developing nations.<ref>{{cite news|title=\"Hope on the Move\" for Haiti|url=http://www.wcjb.com/local-news/2011/01/hope-move-haiti|accessdate=6 May 2014|newspaper=WCJB-TV 20|date=12 January 2011}}</ref> Atkinson serves as secretary, treasurer and director of Hope on the Move.<ref>{{cite web|title=About Us|url=http://www.hopeonthemove.org/about-us.html|publisher=Hope on the Move|accessdate=6 May 2014}}</ref>\n\nAtkinson is the president of Insulin for Life-USA, a non-profit organization that collects insulin, test strips, and other diabetes management supplies and distributes them to needy individuals in developing nations as well as in the United States following natural disasters.<ref>{{cite web|title=Who We Are|url=http://www.ifl-usa.org/2/post/2013/01/who-we-are.html|publisher=Insulin for Life USA|accessdate=6 May 2014|url-status=dead|archiveurl=https://web.archive.org/web/20140506182424/http://www.ifl-usa.org/2/post/2013/01/who-we-are.html|archivedate=6 May 2014}}</ref>\n\n==Selected publications==\n* {{cite journal | last1 = Atkinson | first1 = MA | last2 = Eisenbarth | first2 = GS | last3 = Michels | first3 = AW | year = 2014 | title = Type 1 diabetes | journal = [[The Lancet]] | volume = 383 | issue = 9911| pages = 69\u201382 | doi = 10.1016/S0140-6736(13)60591-7 | pmid = 23890997 | pmc=4380133}}\n* {{cite journal | last1 = Pugliese | first1 = A | last2 = Yang | first2 = M | last3 = Kusmarteva | first3 = I | last4 = Heiple | first4 = T | last5 = Vendrame | first5 = F | last6 = Wasserfall | first6 = C | last7 = Rowe | first7 = P | last8 = Moraski | first8 = JM | last9 = Ball | first9 = S | last10 = Jebson | first10 = L | last11 = Schatz | first11 = DA | last12 = Gianani | first12 = R | last13 = Burke | first13 = GW | last14 = Nierras | first14 = C | last15 = Staeva | first15 = T | last16 = Kaddis | first16 = JS | last17 = Campbell-Thompson | first17 = M | last18 = Atkinson | first18 = MA | year = 2014 | title = The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings | journal = Diabetes | volume = 15 | issue = 1| pages = 1\u20139 | doi = 10.1111/pedi.12097 | pmid = 24325575 | pmc=4282794}}\n* {{cite journal | last1 = Atkinson | first1 = MA | last2 = Ogle | first2 = GD | date = Dec 2013 | title = Improving diabetes care in resource-poor countries: challenges and opportunities | url = | journal = The Lancet Diabetes & Endocrinology | volume = 1 | issue = 4| pages = 268\u201370 | doi = 10.1016/S2213-8587(13)70172-4 | pmid = 24622408 }}\n* {{cite journal | last1 = Staeva | first1 = TP | last2 = Chatenoud | first2 = L | last3 = Insel | first3 = R | last4 = Atkinson | first4 = MA | date = Jan 2013 | title = Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials | journal = Diabetes | volume = 62 | issue = 1| pages = 9\u201317 | doi = 10.2337/db12-0562 | pmid = 23258904 | pmc=3526042}}\n* {{cite journal | last1 = Atkinson | first1 = MA | date = Aug 2011 | title = Evaluating preclinical efficacy | url = | journal = Science Translational Medicine | volume = 3 | issue = 96| page = 22 | doi = 10.1126/scitranslmed.3002757 | pmid = 21849661 }}\n\n==References==\n{{Reflist}}\n\n==External links==\n* [http://pathology.ufl.edu/faculty/experimental-pathology/mark-a-atkinson/ Mark Atkinson] at University of Florida College of Medicine Department of Pathology, Immunology, and Laboratory Medicine\n* [http://diabetes.ufl.edu/research/type-1-diabetes/research-2/atkinson-lab/ Atkinson Lab] at University of Florida Health Diabetes Institute\n* [http://www.jdrfnpod.org/ Network for Pancreatic Organ Donors with Diabetes] (nPOD)\n* [http://www.hopeonthemove.org/ Hope on the Move]\n* [http://www.ifl-usa.org/ Insulin for Life USA]\n* List of [http://www.pubfacts.com/author/Mark+Atkinson authored publications]\n\n{{Authority control}}\n\n{{DEFAULTSORT:Atkinson, Mark}}\n[[Category:1961 births]]\n[[Category:American medical researchers]]\n[[Category:Living people]]\n[[Category:University of Michigan\u2013Dearborn alumni]]\n", "name_user": "Corkythehornetfan", "label": "safe", "comment": "date formats perMOS:DATEFORMATbyscript", "url_page": "//en.wikipedia.org/wiki/Mark_Atkinson_(scientist)"}
{"title_page": "Man of the Hole", "text_new": "'''Man of the Hole''' (also known as \"Indian of the Hole\", {{lang-pt|\u00edndio do buraco}}) is a [[nickname]] used by officials<ref name=\"Revealing\"/> and the media to describe a man who is [[Indigenous peoples in Brazil|indigenous to Brazil]] and lives alone in the [[Amazon rainforest]]. He is believed to be the last surviving member of his tribe.<ref name=\"survival international\">[https://www.survivalinternational.org/articles/3105-the-last-of-his-tribe The last of his tribe] by Fiona Watson; survivalinternational.org</ref> It is unknown what language he speaks or what his tribe was called.<ref name=\"survival international\"/><ref name=\"cracked\">[https://www.cracked.com/article_19976_6-isolated-groups-who-had-no-idea-that-civilization-existed.html 6 Isolated Groups Who Had No Idea That Civilization Existed] by C. Coville; 17 August 2012; [[cracked.com]]</ref>\n\n==Name==\nThe Man of the Hole's nickname derives from the deep hole found in each home that he has abandoned. It was originally believed that these holes were used to trap animals or for him to hide in,<ref name=\"survival international\"/><ref name=\"telegraph\">[https://www.telegraph.co.uk/news/worldnews/southamerica/brazil/6784429/Man-in-the-Hole-lone-survivor-of-Amazon-tribe-hunted-by-Brazilian-ranchers.html Man in the Hole: lone survivor of Amazon tribe hunted by Brazilian ranchers]; 11 December 2009; telegraph.co.uk</ref><ref name=\"slate\">[https://www.slate.com/articles/news_and_politics/dispatches/2010/08/the_most_isolated_man_on_the_planet.single.html The Most Isolated Man on the Planet] by [[Monte Reel]]; 2010; slate.com</ref> but some observers have also speculated that they might have been of spiritual significance to his old tribe.<ref name=\"Revealing\">{{cite news |url=https://www.nationalgeographic.com/culture-exploration/2018/08/brazil-uncontacted-tribe-indigenous-people-amazon-video/ |title=Why Revealing Uncontacted Tribes May Help Save Them |author=Scott Wallace |work=[[National Geographic]] |date=31 August 2018 |accessdate=2 September 2018}}</ref> The holes are narrow<ref name=\"Revealing\"/> and over 6 feet (1.8 meters) deep.<ref name=\"survival international\"/>\n\nHe has also been referred to as:\n* the '''indigenous man in the hole'''<ref name=\"The Guardian\">{{cite news |last1=Phillips |first1=Dom |title=Footage of sole survivor of Amazon tribe emerges |url=https://www.theguardian.com/world/2018/jul/19/footage-sole-survivor-amazon-tribe-emerges-brazil |newspaper=The Guardian |accessdate=8 September 2018 |language=en |date=19 July 2018}}</ref>\n* the '''Man in the Hole'''<ref name=\"telegraph\"/> \n* the '''Last of his Tribe'''<ref name=\"survival international\"/>\n* the '''Loneliest Man on Earth'''<ref name=\"cracked\"/>\n* the '''lone survivor'''<ref name=\"Revealing\"/>\n\n==Biography==\nOther people first became aware of the Man of the Hole's isolated existence in 1996.<ref name=\"Revealing\"/><ref name=\"slate\"/> The rest of his tribe was probably killed in a number of clashes with ranchers and loggers in the 1980s and 1990s, with one expert explaining that \"he should not be seen as a recluse hiding from society. The man is the survivor of a genocide. He didn't choose to live alone.\"<ref name=\"Revealing\"/> In 2007, the Brazilian government's [[Funda\u00e7\u00e3o Nacional do \u00cdndio]] (FUNAI) \"declared a 31-square-mile [8,029 hectare] area around him off-limits to trespassing and development.\"<ref name=\"slate\"/>  His territory was later expanded by 11.5 square miles (3,000 hectares).<ref name=\"survival international\"/>  [[Constitution of Brazil|Brazil's constitution]], ratified in 1988, had already granted indigenous people rights to lands they had traditionally inhabited.<ref name=\"cracked\"/><ref name=\"slate\"/> Since the reserve's establishment, FUNAI has monitored him and tried to prevent intrusions into his area.<ref name=\"Revealing\"/> Despite this, the Man of the Hole was attacked by gunmen in 2009 but managed to survive.<ref name=\"telegraph\"/><ref>[https://www.theguardian.com/world/2009/dec/09/amazon-man-in-hole-attacked Amazon's 'man of the hole' attacked by unknown gunmen] by Rory Carroll; 9 December 2009; theguardian.com</ref><ref>{{cite web|title='Man in the Hole', lone survivor of Amazon tribe massacre, escapes ranchers' bullets|url=https://www.amazonrainforestnews.com/2009/12/man-in-hole-lone-survivor-of-amazon.html|website=Amazon Rainforest News|archiveurl=https://web.archive.org/web/20170318115513/https://www.amazonrainforestnews.com/2009/12/man-in-hole-lone-survivor-of-amazon.html|archivedate=March 18, 2017|date=December 11, 2009}}</ref><ref>[https://indiancountrytodaymedianetwork.com/2009/12/10/amazons-man-hole-attacked-unknown-gunmen-78538 Amazon's 'man of the hole' attacked by unknown gunmen]; 10 December 2009; indiancountrytodaymedianetwork.com</ref>\n\nThough he has avoided further direct contact with others, the Man of the Hole is aware that he is monitored by FUNAI. The agency occasionally left gifts of tools and seeds for him, and thus \"engendered a certain level of trust\". He sometimes signals to observing teams to avoid pitfalls he dug either as defense or to trap animals. In 2018, FUNAI released a video of him in order to raise global awareness of the threats to the uncontacted peoples in Brazil.<ref name=\"Revealing\"/> In the video, the man, now believed to be in his 50s, appeared to be in good health.<ref name=\"The Guardian\"/>\n\n==See also==\n* [[Uncontacted peoples]]\n* [[Ishi]], the last of his tribe in North America\n\n==References==\n<references />\n\n==External links==\n* [https://www.youtube.com/watch?v=ngVW6sRDc1k The Man of the Hole; New Scientist; video]\n\n[[Category:Living people]]\n[[Category:Year of birth unknown]]\n[[Category:Uncontacted peoples]]\n[[Category:Indigenous peoples in Brazil]]\n[[Category:Unidentified people]]\n[[Category:Last living survivors]]\n[[Category:Sole survivors]]\n[[Category:Year of birth missing (living people)]]\n", "text_old": "'''Man of the Hole''' (also known as \"Indian of the Hole\", {{lang-pt|\u00edndio do buraco}}) is a [[nickname]] used by officials<ref name=\"Revealing\"/> and the media to describe a man who is [[Indigenous peoples in Brazil|indigenous to Brazil]] and lives alone in the [[Amazon rainforest]]. He is believed to be the last surviving member of his tribe.<ref name=\"survival international\">[https://www.survivalinternational.org/articles/3105-the-last-of-his-tribe The last of his tribe] by Fiona Watson; survivalinternational.org</ref> It is unknown what language he speaks or what his tribe was called.<ref name=\"survival international\"/><ref name=\"cracked\">[https://www.cracked.com/article_19976_6-isolated-groups-who-had-no-idea-that-civilization-existed.html 6 Isolated Groups Who Had No Idea That Civilization Existed] by C. Coville; 17 August 2012; [[cracked.com]]</ref>\n\n==Name==\nThe Man of the Hole's nickname derives from the deep hole found in each home that he has abandoned. It was originally believed that these holes were used to trap animals or for him to hide in,<ref name=\"survival international\"/><ref name=\"telegraph\">[https://www.telegraph.co.uk/news/worldnews/southamerica/brazil/6784429/Man-in-the-Hole-lone-survivor-of-Amazon-tribe-hunted-by-Brazilian-ranchers.html Man in the Hole: lone survivor of Amazon tribe hunted by Brazilian ranchers]; 11 December 2009; telegraph.co.uk</ref><ref name=\"slate\">[https://www.slate.com/articles/news_and_politics/dispatches/2010/08/the_most_isolated_man_on_the_planet.single.html The Most Isolated Man on the Planet] by [[Monte Reel]]; 2010; slate.com</ref> but some observers have also speculated that they might have been of spiritual significance to his old tribe.<ref name=\"Revealing\">{{cite news |url=https://www.nationalgeographic.com/culture-exploration/2018/08/brazil-uncontacted-tribe-indigenous-people-amazon-video/ |title=Why Revealing Uncontacted Tribes May Help Save Them |author=Scott Wallace |work=[[National Geographic]] |date=31 August 2018 |accessdate=2 September 2018}}</ref> The holes are narrow<ref name=\"Revealing\"/> and over 6 feet (1.8 meters) deep.<ref name=\"survival international\"/>\n\nHe has also been referred to as:\n* the '''indigenous man in the hole'''<ref name=\"The Guardian\">{{cite news |last1=Phillips |first1=Dom |title=Footage of sole survivor of Amazon tribe emerges |url=https://www.theguardian.com/world/2018/jul/19/footage-sole-survivor-amazon-tribe-emerges-brazil |newspaper=The Guardian |accessdate=8 September 2018 |language=en |date=19 July 2018}}</ref>\n* the '''Man in the Hole'''<ref name=\"telegraph\"/> \n* the '''Last of his Tribe'''<ref name=\"survival international\"/>\n* the '''Loneliest Man on Earth'''<ref name=\"cracked\"/>\n* the '''lone survivor'''<ref name=\"Revealing\"/>\n\n==Biography==\nOther people first became aware of the Man of the Hole's isolated existence in 1996.<ref name=\"Revealing\"/><ref name=\"slate\"/> The rest of his tribe was probably killed in a number of clashes with ranchers and loggers in the 1980s and 1990s, with one expert explaining that \"he should not be seen as a recluse hiding from society. The man is the survivor of a genocide. He didn't choose to live alone.\"<ref name=\"Revealing\"/> In 2007, the Brazilian government's [[Funda\u00e7\u00e3o Nacional do \u00cdndio]] (FUNAI) \"declared a 31-square-mile [8,029 hectare] area around him off-limits to trespassing and development.\"<ref name=\"slate\"/>  His territory was later expanded by 11.5 square miles (3,000 hectares).<ref name=\"survival international\"/>  [[Constitution of Brazil|Brazil's constitution]], ratified in 1988, had already granted indigenous people rights to lands they had traditionally inhabited.<ref name=\"cracked\"/><ref name=\"slate\"/> Since the reserve's establishment, FUNAI has monitored him and tried to prevent intrusions into his area.<ref name=\"Revealing\"/> Despite this, the Man of the Hole was attacked by gunmen in 2009 but managed to survive.<ref name=\"telegraph\"/><ref>[https://www.theguardian.com/world/2009/dec/09/amazon-man-in-hole-attacked Amazon's 'man of the hole' attacked by unknown gunmen] by Rory Carroll; 9 December 2009; theguardian.com</ref><ref>{{cite web|title='Man in the Hole', lone survivor of Amazon tribe massacre, escapes ranchers' bullets|url=https://www.amazonrainforestnews.com/2009/12/man-in-hole-lone-survivor-of-amazon.html|website=Amazon Rainforest News|archiveurl=https://web.archive.org/web/20170318115513/https://www.amazonrainforestnews.com/2009/12/man-in-hole-lone-survivor-of-amazon.html|archivedate=March 18, 2017|date=December 11, 2009}}</ref><ref>[https://indiancountrytodaymedianetwork.com/2009/12/10/amazons-man-hole-attacked-unknown-gunmen-78538 Amazon's 'man of the hole' attacked by unknown gunmen]; 10 December 2009; indiancountrytodaymedianetwork.com</ref>\n\nThough he has avoided further direct contact with others, the Man of the Hole is aware that he is monitored by FUNAI. The agency occasionally left gifts of tools and seeds for him, and thus \"engendered a certain level of trust\". He sometimes signals to observing teams to avoid pitfalls he dug either as defense or to trap animals. In 2018, FUNAI released a video of him in order to raise global awareness of the threats to the uncontacted peoples in Brazil.<ref name=\"Revealing\"/> In the video, the man, now believed to be in his 50s, appeared to be in good health.<ref name=\"The Guardian\"/>\n\n==See also==\n* [[Uncontacted peoples]]\n* [[Ishi]], the last of his tribe in North America\n\n==References==\n<references />\n\n==External links==\n* [https://www.youtube.com/watch?v=ngVW6sRDc1k The Man of the Hole; New Scientist; video]\n\n[[Category:Living people]]\n[[Category:Year of birth unknown]]\n[[Category:Uncontacted peoples]]\n[[Category:Indigenous peoples in Brazil]]\n[[Category:Unidentified people]]\n[[Category:Last living survivors]]\n[[Category:Year of birth missing (living people)]]\n", "name_user": "R4nd0m1", "label": "safe", "comment": "added category \"sole survivors\"", "url_page": "//en.wikipedia.org/wiki/Man_of_the_Hole"}
{"title_page": "Space Invaders (Player One song)", "text_new": "{{Infobox song\n| name       = Space Invaders\n| cover      = Space Invaders (Player One single, cover art - Australian version).jpg\n| alt        =\n| caption    = 1979 Australian 7\" sleeve\n| type       = single\n| artist     = Player One\n| album      = Game Over\n| A-side     = Space Invaders\n| B-side     = A Menacing Glow in the Sky\n| released   = 1979\n| format     = [[7-inch single]]\n| recorded   =\n| studio     =\n| venue      =\n| genre      = [[Space disco]]\n| length     = {{Duration|m=3|s=08}}\n| label      = [[Warner Music Group|WEA]]\n| writer     = [[Russell Dunlop]], Bruce Brown\n| producer   = Russell Dunlop, Bruce Brown\n| prev_title =\n| prev_year  =\n| next_title =\n| next_year  =\n}}\n\n'''\"Space Invaders\"''' is a song by Australian songwriters [[Russell Dunlop]] and Bruce Brown, recording under the band name  '''Player One''' (commonly stylised as '''Player [1]''') in 1979. The song is based on the hugely successful 1978 [[video game]] ''[[Space Invaders]]''. It was a [[novelty hit]] in Australia,<ref name=\"dunlopobit\">[http://www.smh.com.au/national/obituaries/a-drummer-for-all-times-20090618-clxo.html A drummer for all times: Russell Dunlop, 1945-2009] (''Sydney Morning Herald'', 19 June 2009)</ref> peaking at No.3 on the [[Kent Music Report]] charts, and ending up as the seventh best selling single in Australia for 1980. It spent 28 weeks on the Australian charts.<ref> Australian Chart Book (1970-1992) Page:391, 432 - David Kent</ref> The song approached [[Music recording certification|Platinum]] status (100,000 sales) in Australia as of October 1980.<ref>{{cite journal |title=Phantom Acts Creating Strong Aussie Presence |journal=[[Billboard (magazine)|Billboard]] |date=October 11, 1980 |page=86 |url=https://books.google.com/books?id=EiUEAAAAMBAJ&pg=PT86 |publisher=[[Nielsen Business Media]] |language=en}}</ref>\nThe single was very popular in South Africa and received much airplay.\n\n==History==\nThe [[arcade game]] of the same name, ''[[Space Invaders]]'', was released by Japanese company [[Taito]] in 1978 and had become a [[Golden age of arcade video games|global phenomenon]] by 1979. The [[Warner Music Group|Warner Music]] office in [[Sydney]] had its own [[arcade cabinet]] of the game, which prompted the idea of a song cashing in on the game's popularity. They took the project to Sydney producer duo Russell Dunlop and Bruce Brown, who took inspiration from the ''Space Invaders'' game to create the song's [[bassline]]. According to Brown: \"We actually went out with a machine before we did the record and recorded all the sound effects of it and had a little fiddle around with it\".<ref name=\"abc\">http://www.abc.net.au/radionational/programs/rarecollections/space-invaders-and-the-birth-of-chicago-house/6301186</ref>\n\nDunlop and Brown also released an album as Player One, ''Game Over''. Dunlop recalled: \"We sat down and wrote a bunch of space songs, but instead of sticking to the concept of the hit, we wandered off into the 'clever' musical genre with fancy time signatures, radical chord progressions and so on. The reply came back for the States that this was intended for 13- to 14-year-olds: 'You've lost us.'\"<ref name=\"dunlopobit\"/>\n\nThe single and album were released in the US under the band name '''Playback''', which Brown and Dunlop had used for other projects, to avoid confusion with the US band [[Player (band)|Player]]. The US version of the album was titled ''Space Invaders''.\n\nThe song was released internationally but failed to chart outside Australia. It was, however, influential in the history of [[electronic dance music]]:<ref name=\"abc\"/> the bassline was re-used by [[Jesse Saunders]] for what is commonly held to be the first [[Chicago house]] record, \"On and On\" (1984), based on a bootleg [[mashup (music)|mashup]] called \"On And On\" that used the original recording of \"Space Invaders\".<ref>{{cite web|title=Jesse Saunders \u2013 On And On|url=http://www.discogs.com/Jesse-Saunders-On-And-On/release/176575|publisher=[[Discogs]]|accessdate=23 May 2012}}</ref><ref name=Saunders2010>{{cite web|url=http://www.beatportal.com/feed/item/black-history-jesse-saunders-and-house-music/|title=Black History Month: Jesse Saunders and house music|archiveurl=https://web.archive.org/web/20100212230432/http://www.beatportal.com/feed/item/black-history-jesse-saunders-and-house-music/|archivedate=12 February 2010|last=Church|first=Terry|publisher=BeatPortal|date=2010-02-09|accessdate=2010-04-10}}</ref>\n\n== Player One discography ==\n\n* '''Australia:''' Space Invaders (3:08) / A Menacing Glow In The Sky (3:13) (7\", WEA 100114)<ref>[http://www.discogs.com/Player-Space-Invaders/release/944745 Player [1&#93; - Space Invaders (Vinyl) at Discogs<!-- Bot generated title -->]</ref>\n* '''Australia:''' ''Game Over'' (LP, WEA 600061)<ref>[http://www.discogs.com/Player-Game-Over/release/1376142 Player [1&#93; - Game Over (Vinyl, LP, Album) at Discogs<!-- Bot generated title -->]</ref>\n** Space Invaders (4:12) / We're All Players (2:28) / Under Control (3:00) / My Babe Is A Cool Player (3:02) / Fire (3:00) / Space Suite (2:22) / Red On The Bottom Line (3:47) / Microprocessor (3:20) / Play Me (1:17) / Game Over (4:12)\n* '''US:''' Space Invaders (4:05) / Red On The Bottom Line (3:20) (12\", Ariola OP-2201)<ref>[http://www.discogs.com/Playback-Space-Invaders/release/201156 Playback - Space Invaders (Vinyl) at Discogs<!-- Bot generated title -->]</ref>\n** released under band name Playback\n* '''Germany:''' Space Invaders (5:50) / A Menacing Glow In The Sky (3:13)  (12\", WEA 70004)<ref>[http://www.discogs.com/Player-Space-Invaders/release/114460 Player [1&#93; - Space Invaders (Vinyl) at Discogs<!-- Bot generated title -->]</ref>\n\n== References ==\n{{reflist}}\n\n[[Category:Australian songs]]\n[[Category:Australian dance songs]]\n[[Category:1979 singles]]\n[[Category:Music based on video games]]\n[[Category:1979 songs]]\n", "text_old": "{{Infobox song\n| name       = Space Invaders\n| cover      = Space Invaders (Player One single, cover art - Australian version).jpg\n| alt        =\n| caption    = 1979 Australian 7\" sleeve\n| type       = single\n| artist     = Player One\n| album      = Game Over\n| A-side     = Space Invaders\n| B-side     = A Menacing Glow in the Sky\n| released   = 1979\n| format     = [[7-inch single]]\n| recorded   =\n| studio     =\n| venue      =\n| genre      = [[Space disco]]\n| length     = {{Duration|m=3|s=08}}\n| label      = [[Warner Music Group|WEA]]\n| writer     = [[Russell Dunlop]], Bruce Brown\n| producer   = Russell Dunlop, Bruce Brown\n| prev_title =\n| prev_year  =\n| next_title =\n| next_year  =\n}}\n\n'''\"Space Invaders\"''' is a song by Australian songwriters [[Russell Dunlop]] and Bruce Brown, recording under the band name  '''Player One''' (commonly stylised as '''Player [1]''') in 1979. The song is based on the hugely successful 1978 [[video game]] ''[[Space Invaders]]''. It was a [[novelty hit]] in Australia,<ref name=\"dunlopobit\">[http://www.smh.com.au/national/obituaries/a-drummer-for-all-times-20090618-clxo.html A drummer for all times: Russell Dunlop, 1945-2009] (''Sydney Morning Herald'', 19 June 2009)</ref> peaking at No.3 on the [[Kent Music Report]] charts, and ending up as the seventh best selling single in Australia for 1980. It spent 28 weeks on the Australian charts.<ref> Australian Chart Book (1970-1992) Page:391, 432 - David Kent</ref> The song approached [[Music recording certification|Platinum]] status (100,000 sales) in Australia as of October 1980.<ref>{{cite journal |title=Phantom Acts Creating Strong Aussie Presence |journal=[[Billboard (magazine)|Billboard]] |date=October 11, 1980 |page=86 |url=https://books.google.com/books?id=EiUEAAAAMBAJ&pg=PT86 |publisher=[[Nielsen Business Media]] |language=en}}</ref>\n\n==History==\nThe [[arcade game]] of the same name, ''[[Space Invaders]]'', was released by Japanese company [[Taito]] in 1978 and had become a [[Golden age of arcade video games|global phenomenon]] by 1979. The [[Warner Music Group|Warner Music]] office in [[Sydney]] had its own [[arcade cabinet]] of the game, which prompted the idea of a song cashing in on the game's popularity. They took the project to Sydney producer duo Russell Dunlop and Bruce Brown, who took inspiration from the ''Space Invaders'' game to create the song's [[bassline]]. According to Brown: \"We actually went out with a machine before we did the record and recorded all the sound effects of it and had a little fiddle around with it\".<ref name=\"abc\">http://www.abc.net.au/radionational/programs/rarecollections/space-invaders-and-the-birth-of-chicago-house/6301186</ref>\n\nDunlop and Brown also released an album as Player One, ''Game Over''. Dunlop recalled: \"We sat down and wrote a bunch of space songs, but instead of sticking to the concept of the hit, we wandered off into the 'clever' musical genre with fancy time signatures, radical chord progressions and so on. The reply came back for the States that this was intended for 13- to 14-year-olds: 'You've lost us.'\"<ref name=\"dunlopobit\"/>\n\nThe single and album were released in the US under the band name '''Playback''', which Brown and Dunlop had used for other projects, to avoid confusion with the US band [[Player (band)|Player]]. The US version of the album was titled ''Space Invaders''.\n\nThe song was released internationally but failed to chart outside Australia. It was, however, influential in the history of [[electronic dance music]]:<ref name=\"abc\"/> the bassline was re-used by [[Jesse Saunders]] for what is commonly held to be the first [[Chicago house]] record, \"On and On\" (1984), based on a bootleg [[mashup (music)|mashup]] called \"On And On\" that used the original recording of \"Space Invaders\".<ref>{{cite web|title=Jesse Saunders \u2013 On And On|url=http://www.discogs.com/Jesse-Saunders-On-And-On/release/176575|publisher=[[Discogs]]|accessdate=23 May 2012}}</ref><ref name=Saunders2010>{{cite web|url=http://www.beatportal.com/feed/item/black-history-jesse-saunders-and-house-music/|title=Black History Month: Jesse Saunders and house music|archiveurl=https://web.archive.org/web/20100212230432/http://www.beatportal.com/feed/item/black-history-jesse-saunders-and-house-music/|archivedate=12 February 2010|last=Church|first=Terry|publisher=BeatPortal|date=2010-02-09|accessdate=2010-04-10}}</ref>\n\n== Player One discography ==\n\n* '''Australia:''' Space Invaders (3:08) / A Menacing Glow In The Sky (3:13) (7\", WEA 100114)<ref>[http://www.discogs.com/Player-Space-Invaders/release/944745 Player [1&#93; - Space Invaders (Vinyl) at Discogs<!-- Bot generated title -->]</ref>\n* '''Australia:''' ''Game Over'' (LP, WEA 600061)<ref>[http://www.discogs.com/Player-Game-Over/release/1376142 Player [1&#93; - Game Over (Vinyl, LP, Album) at Discogs<!-- Bot generated title -->]</ref>\n** Space Invaders (4:12) / We're All Players (2:28) / Under Control (3:00) / My Babe Is A Cool Player (3:02) / Fire (3:00) / Space Suite (2:22) / Red On The Bottom Line (3:47) / Microprocessor (3:20) / Play Me (1:17) / Game Over (4:12)\n* '''US:''' Space Invaders (4:05) / Red On The Bottom Line (3:20) (12\", Ariola OP-2201)<ref>[http://www.discogs.com/Playback-Space-Invaders/release/201156 Playback - Space Invaders (Vinyl) at Discogs<!-- Bot generated title -->]</ref>\n** released under band name Playback\n* '''Germany:''' Space Invaders (5:50) / A Menacing Glow In The Sky (3:13)  (12\", WEA 70004)<ref>[http://www.discogs.com/Player-Space-Invaders/release/114460 Player [1&#93; - Space Invaders (Vinyl) at Discogs<!-- Bot generated title -->]</ref>\n\n== References ==\n{{reflist}}\n\n[[Category:Australian songs]]\n[[Category:Australian dance songs]]\n[[Category:1979 singles]]\n[[Category:Music based on video games]]\n[[Category:1979 songs]]\n", "name_user": "Paddywolf", "label": "safe", "comment": "", "url_page": "//en.wikipedia.org/wiki/Space_Invaders_(Player_One_song)"}
